R/R NHL
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Clinical Study of Novel TLR2-Containing CAR-T Cells Targeting CD19 and CD22 for Relapsed/Refractory B-ALL and NHL (NCT06879262) | Tongji Hospital | 2026-02-15 |
Track R/R NHL automatically
Every clearance here is in the API, with alerts when new ones post.